AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2020 | $1,000 | -97.7% | 15 | -99.4% | 0.00% | -100.0% |
| Q2 2020 | $44,000 | +2.3% | 2,660 | -14.9% | 0.00% | -25.0% |
| Q1 2020 | $43,000 | -47.6% | 3,126 | +23.5% | 0.00% | -33.3% |
| Q4 2019 | $82,000 | +86.4% | 2,532 | +23.9% | 0.01% | +100.0% |
| Q3 2019 | $44,000 | +1366.7% | 2,044 | +1741.4% | 0.00% | – |
| Q4 2018 | $3,000 | 0.0% | 111 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -92.7% | 111 | -92.6% | 0.00% | -100.0% |
| Q2 2018 | $41,000 | -39.7% | 1,508 | -16.0% | 0.00% | -33.3% |
| Q1 2018 | $68,000 | 0.0% | 1,795 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $68,000 | – | 1,795 | +10458.8% | 0.00% | – |
| Q3 2017 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|